Spire Wealth Management’s iRadimed IRMD Stock Holding History

Spire Wealth Management’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$95.6K	Hold	1,000	–	–	﹤0.01%	988
2026 Q1	$96.3K	Hold	1,000	–	–	﹤0.01%	972
2025 Q4	$97.3K	Hold	1,000	–	–	﹤0.01%	998
2025 Q3	$71.2K	Hold	1,000	–	–	﹤0.01%	1114
2025 Q2	$59.8K	Buy	+1,000	New	+$54.8K	﹤0.01%	1138
2023 Q1	–	Sell	-50	Closed	-$1K	–	2534
2022 Q4	$1K	Hold	50	–	–	﹤0.01%	2197
2022 Q3	$2K	Hold	50	–	–	﹤0.01%	1958
2022 Q2	$2K	Buy	+50	New	+$1.79K	﹤0.01%	2363

Other funds holding IRMD

Shaker Investments Cleveland, Ohio $278M AUM 69.83% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return

KPP

Kings Path Partners Sugar Land, Texas $376M AUM 19% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return

1IA

1620 Investment Advisors Plymouth, Massachusetts $161M AUM 30.15% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Spire Wealth Management's IRMD Position: Q2 2026 in Review

Spire Wealth Management held its iRadimed (IRMD) position steady in Q2 2026 at 1,000 shares worth $95.6K. The position accounts for ﹤0.01% of the portfolio, ranked #988.

Spire Wealth Management first reported a position in IRMD in Q2 2022 and has held it in 8 quarters since. The position peaked at $97.3K in Q4 2025. 18 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

Spire Wealth Management held 1,000 shares of iRadimed worth $95.6K as of Q2 2026.
Spire Wealth Management left its iRadimed share count unchanged in Q2 2026.
iRadimed made up ﹤0.01% of Spire Wealth Management's portfolio in Q2 2026, its #988 holding.
Spire Wealth Management first reported a position in iRadimed in Q2 2022 and has held it in 8 quarters since.
Spire Wealth Management's iRadimed position peaked at $97.3K in Q4 2025.
18 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.